Industry interest in personalized genetic testing and nutrigenomics is growing, a survey ahead of Vitafoods Europe suggests.
 
Over 200 nutrition professionals were asked to pick the three most important trends for the future of the industry. A quarter (26%) identified new personalized assessment technologies as a key long-term trend—more than the number choosing provenance and traceability (19%), transparency (18%), and sustainability (11%).
 
The research also reveals a sharp increase in interest in nutrigenomics, the science that allows companies to offer consumers nutritional advice based on their DNA. Fourteen percent of respondents said nutrigenomics would be a key trend over the coming year – up from 8% a year ago.
 
The findings come from a survey of 218 industry professionals by the organizers of Vitafoods Europe, which takes place between May 15 and May 17 in Palexpo, Geneva. Industry trends will lead the Education Program at this year’s event, and the opportunities for personalized dietary advice created by nutrigenetics and nutrigenomics will be key topics of the interactive personalized nutrition workshop. 
 
Commenting on the survey findings, Monica Feldman, president of Consumer Health Strategy Inc., said: “Personalized assessments are already driving the next stage of growth for the industry. For example, quick blood panels can reveal nutritional deficiencies, some of them in a few hours. Major advances have been made in nutrigenomic technology, and nutrition companies are increasingly responding to the opportunities. However, there is a lot more to learn to fully provide a reliable picture of nutrition and the role of genetics.”
 
Meanwhile, the survey suggests there will be a shift in attitudes to gender-targeted marketing of nutrition products. Nearly half (46%) of the industry professionals surveyed said their companies would adopt more gender-neutral marketing over the next ten years, while 11% said there would be more marketing aimed at women, and 5% said there would be more marketing aimed at men.